Clozapine : 1994. Symposium. Garden City NY USA, 1994/02/25.
Cost-effective means different, sometimes competing things to different observers.
In addition to well-known clinical benefits, large payors such as state governments think clozapine and similarly effective antipsychotic medications will yield immediate dollar savings.
They do not consider the need to shift existing resources to community follow-up, the time required to phase out hospital units, and the backlogs of new patients.
In today's financial climate, legislators and other elected officials are reluctant to invest in expensive medicines and then wait for long-term savings.
We must convince those who hold the purse strings that acceptable antipsychotic drugs will be expensive for at least several years to come, until more new and generic drugs appear.
Mots-clés Pascal : Clozapine, Neuroleptique, Psychotrope, Chimiothérapie, Traitement, Analyse coût, Economie santé, Homme
Mots-clés Pascal anglais : Neuroleptic, Psychotropic, Chemotherapy, Treatment, Cost analysis, Health economy, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0019830
Code Inist : 002B02B03. Création : 09/06/1995.